iOnctura to present research at leading scientific conferences in June 2023
GENEVA and AMSTERDAM, June 1, 2023 /PRNewswire/ — iOnctura, a clinical-stage biotech developing selective cancer therapies against targets that play critical roles in multiple tumor survival pathways, today announces that it will be presenting at leading scientific conferences throughout June 2023. The iOnctura team will present the Company’s research on its first-in-class, non-ATP-competitive, allosteric modulator … Read more